Comparative Biochemical and Pharmacodynamic Analyses of

Huiling Li, Zhiqing Wang, Guangyuan Zhao, Yanhong Wang, Xuanwei Xu, Yingping Wang, Ze Zhang, Guanghui Wang

Abstract read

In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

Comparative volatile profiling ofFrontiers in plant science · 2026
Article
Antiviral Efficacy of Lignan Derivatives (-)-Asarinin and Sesamin Against Foot-and-Mouth Disease Virus by Targeting RNA-Dependent RNA Polymerase (3DVeterinary sciences · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Huiling LiCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.

Zhiqing WangCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.

Guangyuan ZhaoCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.

Yanhong WangGinseng and Antler Product Quality and Safety Risk Assessment Laboratory, Ministry of Agriculture and Rural Affairs, Jilin Agricultural University, Changchun 130118, China.

Xuanwei XuGinseng and Antler Product Quality and Safety Risk Assessment Laboratory, Ministry of Agriculture and Rural Affairs, Jilin Agricultural University, Changchun 130118, China.

Yingping WangState & Local Joint Engineering Research Center of Ginseng Breeding and Application, College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.

Ze ZhangCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.

Guanghui WangCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun 130118, China.

Funding

National key research special project of China 2019YFC1710700Science and Technology Department Project from Jilin Province of China 20190304017YY

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-inflammatoryasarininear oedema testessential oil compositionethanol extractGC-MSLC-MSxixin

Identifiers

PMID39458942

DOI10.3390/ph17101301

PMCPMC11509884

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.